Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of three drugs (cyproterone acetate,
medroxyprogesterone acetate and venlafaxine) in the treatment of hot flushes caused by
leuprorelin LP 11.25 milligram (mg) in participants suffering from prostate cancer.